Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-01-01 @ 10:35 AM
Study NCT ID:
NCT04504032
Status:
TERMINATED
Last Update Posted:
2021-10-22
First Post:
2020-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)
Sponsor:
Gates Medical Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-29
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-05
First Submit QC Date:
None
Study First Post Date:
2020-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-29
Results First Submit QC Date:
None
Results First Post Date:
2021-10-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-20
Last Update Post Date:
2021-10-22
Last Update Post Date Type:
ACTUAL